Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- SOFTX.OL
- Price
- 0.07
- Stock movement up
- +0.01 (14.97%)
- Company name
- SoftOx Solutions AS
- Exchange
- (OL ,
- Currency
- NOK )
- Sector
- Healthcare >Biotechnology
- Market cap
- 131.90M
- Ent value
- 146.11M
- Price/Sales
- -
- Price/Book
- 1.77
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -12.21%
- 1 year return
- -74.00%
- 3 year return
- -88.45%
- 5 year return
- -76.43%
- 10 year return
- -
Last updated: 2025-04-15
DIVIDENDS
SOFTX.OL does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 1.77 |
| EV to Sales | -27.46 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 1.95B |
| EPS (TTM) | -0.06 |
| FCF per share (TTM) | -0.06 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | -5.32M |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | -44.05M |
| Net income (TTM) | -60.58M |
| EPS (TTM) | -0.06 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | 828.01% |
| Profit margin (TTM) | 1138.72% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 8.07M |
| Net receivables | 0.00 |
| Total current assets | 9.02M |
| Goodwill | 0.00 |
| Intangible assets | 11.12M |
| Property, plant and equipment | 17.00K |
| Total assets | 96.85M |
| Accounts payable | 9.88M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 22.28M |
| Total liabilities | 22.28M |
| Shareholder's equity | 74.57M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -52.31M |
| Capital expenditures (TTM) | 5.58M |
| Free cash flow (TTM) | -57.88M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -81.24% |
| Return on Assets | -62.55% |
| Return on Invested Capital | -81.24% |
| Cash Return on Invested Capital | -77.62% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.07 |
| Daily high | 0.07 |
| Daily low | 0.06 |
| Daily Volume | 57.3M |
| All-time high | 112.00 |
| 1y analyst estimate | - |
| Beta | -2.23 |
| EPS (TTM) | -0.06 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| SOFTX.OL | S&P500 | |
| Current price drop from All-time high | -99.94% | -12.04% |
| Highest price drop | -99.99% | -56.47% |
| Date of highest drop | 5 Dec 2024 | 9 Mar 2009 |
| Avg drop from high | -59.37% | -11.07% |
| Avg time to new high | 44 days | 12 days |
| Max time to new high | 1244 days | 1805 days |
COMPANY DETAILS
Marketcap
131.90M
Marketcap category
Small-cap
Description
SoftOx Solutions AS, together with its subsidiaries, operates as a medtech and clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway. Its products include SafeDes+, a hand disinfectant for irritated, compromised, and eczematous skin; and EffectDesH, a surface disinfectant, which has a killing/inactivation effect on bacteria, viruses, yeast, fungi, mycobacterium, and spores. The company also provides human wound and infection treatment products comprising SoftOx Wound Irrigation solutions for acute and chronic wounds to prevent and treat infections, including biofilms; and SoftOx Anti-infectives to treat and remove topical infections in wounded and mucosal tissues, such as biofilms, AMR microbes, viruses, and fungi. In addition, it is developing antiseptic solutions for pets and livestock; and inhalation solution, a novel and self-administered inhaled drug that is in Phase II clinical trial for early treatment and prevention of influenza-like illnesses. SoftOx Solutions AS was founded in 2012 and is headquartered in Fornebu, Norway.
Employees
7
Website
Investor relations
-
SEC filings
CEO
Country
Norway
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found